These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

679 related items for PubMed ID: 25815776

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y, Chen D, Su Z, Li Y, Liu J, Jin L, Shi M, Jiang Z, Qi Z, Gui Y, Yang S, Mao X, Wu X, Lai Y.
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y, Zheng D, Pan L, Dai Y, Cai S, Zhao L, Zhu H.
    Eur J Pharmacol; 2019 Oct 05; 860():172536. PubMed ID: 31310753
    [Abstract] [Full Text] [Related]

  • 11. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C, Wang S, Ye ZQ, Chen ZQ.
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec 05; 36(6):852-858. PubMed ID: 27924503
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
    Chen D, Li Y, Yu Z, Li Y, Su Z, Ni L, Yang S, Gui Y, Lai Y.
    Mol Med Rep; 2015 Aug 05; 12(2):3061-6. PubMed ID: 25936999
    [Abstract] [Full Text] [Related]

  • 14. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z, Tang ZY, He Y, Liu LF, Li DJ, Chen X.
    Oncol Res Treat; 2014 Aug 05; 37(11):658-64. PubMed ID: 25427583
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.
    Liu L, Li Y, Liu S, Duan Q, Chen L, Wu T, Qian H, Yang S, Xin D.
    Tumour Biol; 2017 Jun 05; 39(6):1010428317711951. PubMed ID: 28639901
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
    Huang B, Luo W, Sun L, Zhang Q, Jiang L, Chang J, Qiu X, Wang E.
    Int J Oncol; 2013 May 05; 42(5):1734-42. PubMed ID: 23525486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.